{"url_path":"/sec/acet/10-k/2026/item-15","section_key":"item-15","section_title":"Item 15 Exhibits, Financial Statement Schedules.","topic":"sec","document":{"doc_type":"10-K/A","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1720580/0001720580-26-000042-index.html","accession_number":"0001720580-26-000042","cik":"0001720580","ticker":"ACET","issuer_name":"Adicet Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1720580/0001720580-26-000042-index.html","primary_entity_key":"0001720580","primary_entity_name":"Adicet Bio, Inc."},"word_count":197,"has_tables":true,"body_markdown":"Item 15. Exhibits, Financial Statement Schedules.\n\n \n\nThe following documents are filed as exhibits to this Amendment:\n\n \n\nEXHIBIT INDEX\n\n \n\n \n\nExhibit\n\nNumber\n\n \n\nDescription of Exhibit\n\n \n\n \n\n \n\n  31.1*\n\n \n\n[Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](acet-ex31_1.htm)\n\n \n\n \n\n \n\n  31.2*\n\n \n\n[Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](acet-ex31_2.htm)\n\n \n\n \n\n \n\n101.INS*\n\n \n\nInline XBRL Instance Document\n\n \n\n \n\n \n\n101.SCH*\n\n \n\nInline XBRL Taxonomy Extension Schema Document\n\n \n\n \n\n \n\n101.CAL*\n\n \n\nInline XBRL Taxonomy Extension Calculation Linkbase Document\n\n \n\n \n\n \n\n101.DEF*\n\n \n\nInline XBRL Taxonomy Extension Definition Linkbase Document\n\n \n\n \n\n \n\n101.LAB*\n\n \n\nInline XBRL Taxonomy Extension Label Linkbase Document\n\n \n\n \n\n \n\n101.PRE*\n\n \n\nInline XBRL Taxonomy Extension Presentation Linkbase Document\n\n \n\n \n\n \n\n104*\n\n \n\nCover Page Interactive Data File\n\n \n\n* Filed herewith.\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\n \n\nAdicet Bio, Inc.\n\n \n\n \n\n \n\nDate: May 20, 2026\n\nBy:\n\n/s/ Chen Schor\n\n \n\n \n\nChen Schor\n\nPresident, Chief Executive Officer and Director\n\n(Principal Executive Officer)"}